Clinicians must weigh risks of geographic atrophy medications

WAILEA, Hawaii — Clinicians need to balance the efficacy of geographic atrophy medications with the risks, according to a speaker at Retina 2024.
Diana V. Do, MD, said retina specialists take several factors into account when selecting a medication for their patients.
“We look at efficacy, safety and other challenges, such as cost and treatment burden, before deciding on the optimal therapy,” she said. “With the advent of two new FDA-approved therapies for geographic atrophy, it’s more important than ever to take into account all these factors when deciding on a

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart
This website uses cookies and asks your personal data to enhance your browsing experience.